Physician profile
Gary Grindstaff
NPI 1912995895
$2,917.76
in general payments reported to CMS, 2019-2025
26 companies · $606 in 2025
The $606 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $227 · 2021: $547 · 2022: $515 · 2023: $562 · 2024: $36.05 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,204.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $527.90 | 2019-2025 | Via Matrix |
| Misonix INC | $346.56 | 2019-2021 | |
| Smith+Nephew, INC. | $312.35 | 2021-2025 | Stravix Pl, Grafix Pl, Regranex |
| Integra Lifesciences Corporation | $175.54 | 2021-2022 | |
| Paragon 28, INC. | $174.49 | 2022 | |
| Inari Medical, INC. | $146.48 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $131.13 | 2023 | Penumbra System |
| Angiodynamics, INC. | $123.24 | 2023 | Auryon Laser System 100-120 Vac |
| Kerecis Limited | $119.55 | 2019 | |
| Treace Medical Concepts, INC. | $109.35 | 2022-2025 | |
| Anika Therapeutics, INC. | $101.45 | 2021 | |
| Stryker Corporation | $94.55 | 2019-2021 | |
| Vaporox, INC. | $92.26 | 2023 | Vht-200 Wound Treatment System |
| Ortho Solutions INC | $86.80 | 2019 | |
| Paratek Pharmaceuticals, INC. | $79.39 | 2024-2025 | Nuzyra |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $58.21 | 2025 | Prevena, Activ.A.C. Ion Progress, V.A.C. Veraflo Cleanse Choice |
| Terumo Bct, INC. | $47.49 | 2022 | |
| Reapplix INC. | $35.73 | 2022 | |
| Innovation Technologies INC | $34.71 | 2023 | Irrisept |
| Amgen INC. | $31.47 | 2025 | Krystexxa |
| Convatec INC. | $20.03 | 2025 | |
| Bioventus LLC | $18.05 | 2022 | |
| Mimedx Group, INC. | $15.57 | 2024 | |
| Resmed Corp | $14.34 | 2023 | |
| Reprise Biomedical, INC. | $10.79 | 2025 | Miro3d |
| Advanced Oxygen Therapy INC. | $10.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Grindstaff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.